Ishares Biotechnology Etf Alpha and Beta Analysis
| IBB Etf | USD 138.66 0.21 0.15% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as iShares Biotechnology ETF. It also helps investors analyze the systematic and unsystematic risks associated with investing in IShares Biotechnology over a specified time horizon. Remember, high IShares Biotechnology's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to IShares Biotechnology's market risk premium analysis include:
Beta 0.48 | Alpha (0.07) | Risk 1.29 | Sharpe Ratio (0.03) | Expected Return (0.04) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
IShares |
IShares Biotechnology Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. IShares Biotechnology market risk premium is the additional return an investor will receive from holding IShares Biotechnology long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in IShares Biotechnology. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate IShares Biotechnology's performance over market.| α | -0.07 | β | 0.48 |
IShares Biotechnology expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of IShares Biotechnology's Buy-and-hold return. Our buy-and-hold chart shows how IShares Biotechnology performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.IShares Biotechnology Market Price Analysis
Market price analysis indicators help investors to evaluate how IShares Biotechnology etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading IShares Biotechnology shares will generate the highest return on investment. By understating and applying IShares Biotechnology etf market price indicators, traders can identify IShares Biotechnology position entry and exit signals to maximize returns.
IShares Biotechnology Return and Market Media
The median price of IShares Biotechnology for the period between Sat, Nov 2, 2024 and Fri, Jan 31, 2025 is 137.9 with a coefficient of variation of 3.25. The daily time series for the period is distributed with a sample standard deviation of 4.49, arithmetic mean of 138.06, and mean deviation of 3.78. The Etf received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Crestwood Advisors Group LLC Sells 615 Shares of iShares Biotechnology ETF | 11/06/2024 |
2 | Bond Devick Financial Network Inc. Reduces Holdings in iShares Biotechnology ETF | 11/11/2024 |
3 | Should You Invest in the Invesco Biotechnology Genome ETF | 11/20/2024 |
4 | RS Crum Inc. Sells 127 Shares of iShares Biotechnology ETF | 11/27/2024 |
5 | Should You Invest in the iShares Biotechnology ETF | 12/03/2024 |
6 | Is iShares Biotechnology ETF a Strong ETF Right Now | 12/09/2024 |
7 | Altimmune Added to Nasdaq Biotechnology Index | 12/19/2024 |
8 | SeaCrest Wealth Management LLC Has 427,000 Stake in iShares Biotechnology ETF | 01/17/2025 |
About IShares Biotechnology Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including IShares or other etfs. Alpha measures the amount that position in iShares Biotechnology ETF has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards IShares Biotechnology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, IShares Biotechnology's short interest history, or implied volatility extrapolated from IShares Biotechnology options trading.
Build Portfolio with IShares Biotechnology
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out IShares Biotechnology Backtesting, Portfolio Optimization, IShares Biotechnology Correlation, IShares Biotechnology Hype Analysis, IShares Biotechnology Volatility, IShares Biotechnology History and analyze IShares Biotechnology Performance. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
IShares Biotechnology technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.